I aged by wounding, microorganisms from the surrounding skin, other body sites, or from exogenous sources have access to a warm, nioist environment. Whether organisms survive and multiply depends on their ability to evade tlie body's immune system, and whether essential chemical and physical requirements are met.
Wound contaminants may not persist, but those species that do grow and divide may establish either wound colonizzltion or wound infection, The outcome depends on the interaction of complex h a t and microbial factors (Emmerson, 1998) . The size, Position and duration of a wound, local Perfusion (dissolved oxygen levels) and host imniunocompetency are balanced against the number aiid type of invading microbial species and thc preseiice of foreign bodies (jncluding necroric rissue sliid eschar).
The presence of niicroorgaiiisiiis in n wound is not iinusual, but not all wounds Support the Same range siid number of species (Cooper and Lawrence, 2996n). Elective wounds ure usunlly subjcct to preoperative antisepric mensures and aseptic surgical techniques, and tlierefore infection is minimized and healing often proceeds within expected timeframes. Trauiiiatic wounds are niore likely to contain devitalized tissue and debris, and to be contaniinated with microorganistns from environmental sources; consequently, infection rates are higher.
Chronic wounds, i.e. of over 6 weeks duration (Dale et al, 1983) , such as leg ulcers or pressure ulcers are inevitably colonized with a mixture of species and rnany of these are potential pathogens. The developmeiit of infection in chronic wounds often reflects host susceptibility.
Wound infection is one of the most signifiCant factors that delay healing. Alrhough a Consensus on the impact of specific microorganisms On the healing process is not yet agreed, the development of infecrion causes I
PREVENTWE MEASURES
Measures to prevetit wound infection and delayed liealing Situations are based on sound tissue viability principles (Fipre I ) , which are:
Identify aetiology of wound Reinove any continuing intrinsic and extrinsic causative factors such as venous hypertension aiid shearing pressure I . Eliminate or redwce any factors that may impair healing such as malnutrition, hyperglycaemia and anaemia among others * Iniciate most effective therapy a t outset; do not use holding o r 'wait and See' treatnients just because rhey are more convenient 0 Use universal infection control precautions to prevent Cross-contamination from the wound 0 Remove necrotic and foreign material 0 Allow drainage of wound exudatdpus, in particnlar from sinuses (this does not preclude iise of occhsive dressings but does help to determine dressing frequency depeiident on the absorbency of the individual product 0 Observe closely for signs of Change at all dressing changes, in particular those representing a delay in healing or infection Construct a care plan tliat details expected Progress so that delays be detected at the earliest opportunity I, Use a framework to guide decision making for undesired events (Kingsley, 200 1) Modem 'moist wound healing' dr-essings have been shown to be vduable in infection control. They form part of the non-nlicrobiological approach to control the wound bioburden.
Some occlusive dressings such as hydrocolloids have both bacterial and viral barrier properties. These can be used to 'contain' pathogens within the wound environment thus reducing the spread and Cross-infection (Bowler et al, 1993) . Hydrocolloids have also been shown to reduce the airborne distribution of organisnis at dressing cliange tlirough aerosol formation (Lawrencc, 1994) . In general, occlusive dressings are associated with a lower Overall wound infection rate tlian non-occlusive dressings (Hutchinson and Lawrence, 1991) .
Dry dressings such as gauzes stick to tlie wound. O n removal, the traiiniatic detachment has been demonstrated to spread bacteria by aerosol formation (Lawrence et al, 1992) . In hospital clinics this is likely to be a Eactor in the spread OE infectiorrs. While tkere is no evidence that traditionai dry dressings have any role in infection control and may even lead to an increased rare of infection, some modern dressiiigs have evidence to supPort their use in this context.
A hydrofibre dressing, Aqiiacel (ConvaTec), bas been found to bind bacteria and thereby 'contain' die spread of pathogens. In a study using an in vitro wouid iiiodel seeded with Staphylococcus aurcus, Bowler et al (1999a) have compared a number of fibrous dressings.
Results Show Aquacel to be most effective in binding the bacteria (P<O.OOZ), followed by the alginates Algosteril (Beiersdorf) and Kaltostat (ConvaTec) .
"HERAPEUTiC MEASURES
Active steps taken to reduce colonizarion or Counter-infecrion depend upon the nature of the wound, Status of the Patient md the patliogenicity of the organism(s) involved. An Organ transplant Patient threatened with a methicillin-resistant S. aureus (MRSA) infectim in hidher surgical wound is at greater risk. This is because hisher immunosuppressed Status puts him/her at higher risk of life-threatening infection than a Patient with a long-standing leg ulcer known to be colonized but with minimal host reaction.
The bacterial loading, or bioburden, of the wound may influence the healing rate and is a particularly important factor in patients known to be 'at risk', e.g. those known to have campromised healing or host response, diabetes or ischaemia.
Antibiotics
Appropriate systemic antibiotics are consideted to be essential for the treatment of Severlty clinically infected wounds (ßowler et al, 2001) . The use of topical antibiotics is not justified for the routine treatment of colonized or infected wounds (Drug and Therapeutics Bulletin, 1991). There is evidence that the routine use of antibiotics in the management of clinically infected leg ulcers is of no benefit (AIinovi et al, 1986) and there is some evidence that it may be harmful by encouraging the colonization by resistant organisms (Huovinen et al, 1994) .
Topical antibiotics caii provoke delayed hyperseositivity reactions (Zaki et al, 1994) 
Antiseptics
For many, the use of antiseptics in wound carc is biased by the 'bad press' given to eusol and the confusion over iodine compounds. The value and use of eusd has led to vigorous debate and polarization of healthcare professioiials into a majority that vehemently oppose its wse under any circunstances (Leaper, 1992) and a ininority tliat still regard it OS useful. The value and use of topicsll antiseptics in wound care has been debated for many years. In the UK in particular, the use of hypochlorites such as eusol is controversial (Moore, 1992) .
The Consensus on eusol, especially among nurses, is that it has no place in wound care, regardless of the concentration used (Roe et al, 1994) . This view is based on evidence that it is rapidly deactivated in the presence of pus, , is paiiiful to the Patient and delays heeling by damaging cells and capillarics (Leaper, 1988) .
Iodine compouncls have also attracted criticism (Rodeheaver, 1990) . The main argument against the use of such agcnts is their potential toxicity (Lawrence, 1998a) -a factor related to coticentratioti nnd exposure -and the attendant delay in healing compared to untreated controls (Brennan and Leaper, 1985) .
CLlNlCAl EVlDENCE TOR THE USE

OF TOPICAL ANTISEPTICS
Careful and objective review of the literature reveals that the iise of many antiseptics in wound management miw be subject to a riskbenefit assessment of possible local toxicity w i t h beneficial antibacterial action (Kaye, 2000) . Brennan and Leaper (1985) advise balancing the beneficial antimicrobial effects and bioavailability with possible cellular toxicity before use.
In solution form, antiseptics are used to irrigate or cleanse the wound. This, by definition, means a short period of contact with the tissues. Solutions are, therefore, concentrated in Order to luve tlie desired effect -this increases the likelihood of tissue toxicity and delayed healing. Antisep tic agents incorporated i rito dressings are in contact for much longer and can, therefore, be more dilutc, less toxic aiid exert a proloiiged antimicrobial effect.
The ideal antiseptic will have the following key attributes (Morison, 1990): broad spectrum of activity; low potential for resistance; non-toxic; rapid acting; not irritant or a sensitizer; and effective, even in the presence of exudate, pus, slough, etc.
Xodine
Iodine, particularly in the safe, modern iodophor povidone-iodine (polyvinyipyrrolidone iodine complex, or PVP-I) and the cadexomer is a very useful bacteriostatic and bactericidal agent being active against MItSA and other pathogens (Mertz et al, 1999) . The use of PVP-I as a preswgical Skin aiitiseptic is unquestioned although its value in wound antisepsis is subject to debate (Thoinas, 1988; Rodeheaver, 1990; Goldenheim, 1993; Lawrence, 1998a,b; Gulliveq 1999) .
Concerns about toxicity and impaired healing relate mainly to products that contain elemental iodine, although PVP-I is also implicated (Kramer, 1999) . The newer products, e.g. Ioban (3M Health Care), Inadine (Johnson & Johnson Medical), Iodosorb (Smitli & Nephew Mealthcare), appear to be safer and have a very wide spectrum of nctivity (Gilchrist, 1997a; Sundberg and Meller, 1997) . In ehe USA, the Food and Drug Administration maintains that PVP-I in 5-10% solutiotis does not adversely affect heding (Fcderal Register, 1994) , although a later review of published data by Kramer (1 999) disputes tliis view.
l o b e iodophor is available in a range of concetitrations as medicated dressings (e.g. Inadine, Johnson 8c Johnson Medicd, Iodoflex, Smith & Nephew Healthcare), solutions and ointments (e.g. Betadine, SSL International), powder and Spray (e.g. Savlon Dry powdeq Novartis Consumer Health), and incise drapes (Ioban, 3M Health Care). PVP-I gradually releases free iodine, which has a broad spectrum of antimicrobial activity, including MRSA (McLure and Gordon, 1992; Lawrence, 1998b) . The slow release from the iodophor is intended to optimize activity and to reduce toxicity.
The cadexomer is a Polysaccharide starch lattice contilining 0.9% elemental iodine that is released OLI exposure to exudate (Lawrence, 1998a) and has antimicrobial activity for LIP to 3 days (Mertz et al, 1999) . It has been extensively evaluated in B variety of aciite and chronic wouiids and €ound to be safe atid effective (Sundberg and Meller, 1997) .
Tlie PVP-I containing dressings such as Inadinc (a sterile knitted viscose dressing imptegnated with 10% PVP-I in a water-soluble base) and Ioban (iodophore incorpora ted onto a film) provide sustained release of low levels of free iodine. Consequently, this and other modern iodinated dressings sliould oiily be used on exuding wounds for best effect.
Iodine is also available as the alcoholic tincture aiid as Iodoform, neither of which is regarded ns being valuable in wound management because of pain and limited bacterial activity respectively.
Siluer
Silver and silver compouiids have been routinely used as bactericidals for over a century.
It is generally recogiiized as a safe, broad spectruni agent witli only irritation and Skin discolouration (argyria) reported for the inorganic nitrate Solution (Wright et al, 1998a).
Silver acts czs a heavy meta1 by impairiiig the bacterial electron transport system and some of its DNA functions (Russe11 atid Hugo, 1994; Cervantes and Silver, 1996) . To da this, the 'active' agents -silver ionshave EO be bioavailslble (i.e. to be able to mter the cell), at the correct concentration in solution (Demliiig and DeSanti, 2001).
Silver iiitrate was probably tlie fitst silver compouiid used on wounds where it has aii astringent aiid irritatiiig effect. As a tesult of these Problems it is rnrely used today except for the occasional use in teducing hypergranulation. The esterification (chemical bonding) of silver witli a sulphonamide antimicrobial Wright et al, 1998a,b; Yin et al, 1999) . In any formulation, the way in whicb silver is incorporated and how it interacts with microorganisms, i.e. its bioavailability in Solution, is critical in deterniining its antimicrabial efficiency atid its safety (Demling and DcSanti, 2001) .
Actisorb Plus (recently renamed Actisorb Silver 220, Johnson & Johnson Medical) contains silver impregtiared onto an activated charcoal Cloth (Williams, 1994) . It is claimed to be effective against sl wide range o€ microorganisms, nlthough there is only oiie stibjective published report of coinparative clinical datn (Millward, 1991) . Arglaes (Maersk Medical) is avslilable as a slowrelease filiii dressing polymer with silver ions (Williams, 1997) . Acticoat Antimicrobial Barrier dressing (Westaim Co.
-not yet available in the UK) is an antimicrobial barrier dressing which has also been shown to be effective against a wide range of organisms (Yb et al, 1999) .
Although the delivery sys tems vary, the mode of action prhciple is the sanie in each case. There is currently very little clinical evidence available to suipport these products. Their rationale is based On in vitro studies (Furr et al, 1994; Wright et al, 1998b) . Preliminary findings from an in vitro wound model (Bowler et al, 2000) suggests that not all can be expected to be equally effective. In heavily exuding wounds, the presence of proteinaceous material in wound Buid is likdy to bind to the charcoal layer in Actisorb Silver 220, thus reducing Figure 2 illustrates the rationale for iodine and siIver dressings in the treatment of criticalIy colonized and infected wounds.
Proflavine
Proflavine is an acridine derivative (a compound originally used in the manufacture of dyes) available as Proflavine Cream, British l'harmaceutical Codex (BPC), solution BPC and as the hemisulphate, which has been in use for niany years as a slow-acting mildly bactetiostatic (i.e. inhi bits bacterial growth) agent in wound management. In particulal; proflavine is still widely used prophylacticaily as a gauze soak for wound packing even though it has been found to be inferior to an alginate dressing in this respect (Gupta et al, 1991) . There is no reliable evidence that it is effective in this context, or that it has any clinical benefits. Indeed, there are reports of mutagenicity -gene and chromosomal mutations -of proflavine on bacterial (Iwamoto et al, 1992 ) and cell cultures (DeMarini et al,  1988) , raising questions about its safety.
Chlorhexidine compouncls
These are useful antiseptics for skin and are highly effective for hand washing and surgical scrub. They bind to the Stratum corneum and have a persisting activity, remaining active for at least 6 hours after application (Kaye, 2000 sepric due to the release of oxygen, an oxidizing agent, on contact with the tissues. There are safety concerns about using hydrogen Peroxide solutions on Open wounds because of reports of tissue embolism (Scott Ward and Saffle, 2995). Hydrogen Peroxide is also available as a 1.5% creain (Hioxyl, Quinoderm) for desloughing wounds.
Potassium permangatrate
Weak solutions of this oxidizing agent (1 part in 5000, 1 part"Jn 10000) are used ns soaks to cleanse aiid deodorize eczeinatous wounds and leg ulcers. Although favoured by dermatologists, there is no evidence published to supporr their use (Roe and Cullum, 1995) .
WOUND CLEANSING
The value of cleansing wounds rests with the removal of excess exudate, foreign bodies, including dressing residues, necrotic tissue, loose slough and wound enge crusting (which is fibrin, dehydrated exudate and dressing residue). Removal of all these and leaving the wound moist will ensure that healing will be assisted to Progress unhindered. Cleaning that does not seek to achieve any of these aims is uiilikely to be of vnliie nnd is niorc likely to cnuse hnrm by damaging frngile new tissue growth, thereby delnyitig Iiealitig.
However, if one considcn wouiid cluaning to include the periwouiid skin, t h~i reinavnl of exiidate and dressing adliesive residues should reduce the likelihood of mncerntion, which can extend wouiids and excoriation from exudate, eiizynies, bacterial roxins and Skin pH disturbance (Cutting, 1999 water. The use of tap water makes cleansing convenient as it can be done in a sink under running water, in the batli or shower, or in a bucket for leg ulcers. These processes have die added advantage of ease of cleaning surrounding skin.
Pressurized irrigation can be achieved notably with commercially available acrosol spray cans. The pressure must be adequate eiiough to dislodge loose debris and sIough without causing tissue damage. Whirlpool baths, for exaniple, niay ca~isc daniage to tissues in leg wounds (Oliver, 1997). Spray mns deliver a pressurized stream of saline at 8 Pounds per Square inch (55 kPa), which is considered Optimum for effectiveness. However, such delivery onto the flat surface. of most wounds generates aerosols which must offer a high risk for cross-contamination of the practitioner and surrounding environment, making them inadvisable for use anywhere but the home (avoids nosocomial infection risk) with suita ble protective clothing. To improve diese devices, a disposable splash guard would make them more viable.
Microbial colonization of Open wounds is inevitable and cleansing can lower the bioburden transiently. The purpose of cleansing (whether pressurized or not and with whatever fluid) is to aid removal of necrotic tissues and foreign bodies which provide ehe medium for overgrowth, a phenomenon which can cause clelay in healing.
As For the use of antiseptic solutions as cleansing agents, Thomlinson (1997) notes that tlie duration of contact is generally too short to be effective.
WOUND DRESSINGS
Malodour is common in chronic wounds. It is associated with aerobic and anaerobic bacteria colonizing or infecting the wound (Bowler et al, 1999 b) . The use of odour-Controlling dressings such as those containing charcoal, e.g. Actisorb Silver 220 Wohnson & Johnson Medical), CarboFlex (ConvaTec), Lyofoam C (SSL Iiiternational), can be very helpful (Thomas et al, 1998a) . Indeed, of this category only CarboFlex currently has the capacity to manage exudate (Thomas et al, 1998a) and still control odour effectively (Thomas et al, 1998b) . This is atrributable to an absorbent wound contact layer thnt manages the exudate, restricting exudate access to the charcoal adsorbent layer. While odour control alone does not eradicate infection or, indeed, alter bacterial growth, it does have substantial Patient quality of life benefits and should, tlierefoore, be an adjunct to any topical andor systeinic antibacterial therapy (Haughton and Young, 1995) .
The use of modern dressings in infectioli control shows great promise. Medicated (silver and iodine complexes) dressings can be useful in the local control of bacterial biaburden provided the active ngents -silver ions and elemental iodine -are available in Solution at an appropriate concentration over time. Such dressings will, in tun, assist in infection control by reducing the iiuinbers of wound pathogens available for Cross-infection.
Dressings containing antibiotics generally have a diminishing place in wound treatment primarily because of antibiotic resistance. However, a case can be made for the use of topical metronidazole gel in the palliative treatmen t of malodorous malignant (fungating) wounds where odour is a major Problem and, because of the terminal nature of the disease, antibiotic resisrance is not an issue (Rice, 1992).
'
CHRONIC WOUNDS
Tlie detailed reviews condiicred by O'Meara et al (2000, 2001) and the Scotrisli Intercollegiate Guideliiies Nctwork (SIGN) (1998) have fouiid little cvicleiicc to support tlie routine use of systemic antihiorics in patients with chronic wounds. Acutc infections in chronic waunds shoulcl, Iiowevei; I)e treated with systeinic antibiotics.
Topical dressing crectms or ointments thnt provide a sufficient delivery of an aiitiseptic agent (e.g. silver or iodine) niny be useful. However, the use of povidone-iodine in solution as a wound cleanser is not justifjed (Leaper, 1994; Burks, 1998) . Solutions used as rinses do not have sufficiently long contact time to be of much effect. Cleansers that rely on pressure, as in aerosol Sprays of normal saline or containing Liocompatible surfactants to help remove necrotic material are effective, but infection control measures niust be carefully considered before use.
SURGICAL WOUNDS
Clean surgery carries a small (1-5%) risk of postoperative wound infection, whereas 'dirty procedures' such as those involving the 27% (Nickols, 1998) .
Minimizing the iiicidence of infection relies on adequate asepsis, antisepsis and preservation of local host defences (Hunt, 1981) . Asepsis involves effective infection coiitrol to minimize exogenous contamination during surgery. Aiitisepsis involves the use of skin antiseptics and prophylactic antibiotics before surgery (Hansis, 1996) . Recent guidelines on the prevention of surgical site infection have been published (Mangram, 1999) . The emphasis on surgical wound healing is rapid Perfusion, as ischaemic tissue beals poorly and is easily infected (Hunt and Hopf, 1997) . Healing and resistance to infection improves with increased local blood supply, and hence tissue oxygenation. Delivery of antibiotics, systemically dosed, to the infected wound also depeiids on perfusion.
Antibiotics given at the time of injury w i l l reduce, but not eliminate, the risk of infection.
Iri one-third of wound infections, bacteria cultured from the wound are susceptible to the prophylactic antibiotic provided. The key factors involved here are patients with hypoxia and local Perfusion Problems (Hunt nnd Hopf, 1997). In such instances, it is easy to make a case for prophylactic and therapetitic antiseptics, particularly tliose provided by sustained dosing from 'medicated' dressings.
The risk assessnient for surgical wounds has been defiried by the Americcln SENK study of tlie effect of nosocomial infection (Study of the Effect of Nosocomisll Infection Control) (Haley et al, 1985) , This and other factors liave beeil sunimarized by Kingsley (2001) .
DlSCUSSlON
Antiniicro bial agents have been applied to wounds for thousands of years (MoeUering, 1995) , but the relentless emergence of resistant strains has forced the continued search for novel agents. As each new type of antirnicrobial agent has been introduced into clinical practice, changes in niicrobial sensitivity have been observed, At the outset, there are always some strains that art not inhibited by a new agent (i.e. possess intrinsic resistance), and some species that are susceptible.
Use of a new antimicrobial agent iimits the growth of susceptible strains, but eventually 'resistant strains always emerge. These agents do not iiiduce the formation of resistance genes, but merely provide an environment in wliicli sensitive species are curtailed and resistant species flourisli. The eniergence of wound pathogens with Patterns of niultiplc antibiotic resistaiice is having serious coiisequences in the hospital environment (Morgan, 2000) , nursing homes (Fraise et al, 1997) , and in the coinmiinity (Cookson, 2000) . The Situation is compounded by the increasing costs of senl-cliing for new antimicrobials aiid tlie decreasing rate of discovery of new agents (Moellering, 1995) .
At one time it was considered thnt the cievelopment of resistance to antiseptics aiid disinfectants was remote, But tliis Iias been shown to be incorrect (McDonnell m d Russell, 1999) . Certain species, such as bacterial Spores, mycobacteria and Gram-negative bacteria possess intrinsic resistance, but plasmidmediated acquired resistance to antiseptics and disinfectants in several bacteria has been reviewed (McDonnell and Russell, 1999) .
The presence of different species of inicroorganisms in the wound has been linked to delayed healing and wound odour. Trengove et al (1996) have found a significantly greater Chance of impaired healing when four or inore species are present. WhiIe the definition of wound infection itself is not acceyted unanimoiisly (Gilchrist, 1997b; Lmper, 1998) , the consensus is tlint the signs are recognized as s u p piirntion, cellulitis, lymphaiigitis, and hacteraemia. Maiiy rexts refer to c? figure of 109 organisnis per grain of tissue as n criterion for infection (Thoinpson and Smitli, 1994) . This growth density, in isolation, has no confirmed connectioii to tlie threshold or degcee of immune respoiise or to healing (Cooper nnd Lawrence, 1996b ) and none at all if no acciirate sanipling hes been conducted (Robsoii, 1999) .
In 'critical' colonization, ehe niimbers o€ organisms and of species increases above tlie levels found in tlie colonized wound. Clinical signs for critical colonization may be apparent, although primarily it is a micro biological criterion that may only become apparent retrospectively once infection is diagnosed. There is evidence that delayed healing or die f a h r e to heal in a chronic wound which has no signs of cliaical infection, suggestive of critical colonization, is directly related to the microbial bio burden, notably haemolytic streptococci and anaerobes (Halbert et al, 1992) . In this study, the implications for wouiids colonized with these organisms were that they had been present for longer, were larger, and had a significantly delayed healing time. One iniplication of these findings is that early nnd appropriate intervention caii avoid Progression to critical colonizntion and to infection, thus potentinlly iinproving healitig rates aiid reducing the risk of Cross-iiifection.
Where overt infection exists, systemic antibiotics are usually appropriate for firstline treatnient witli topicnl treatiiieiits being usefiil adjuncts, pnrticularly in the case of poor Perfusion. Non-hcnling wounds where critical colonization is suspected or confiriiied may also be appropriate for such treatment.
In the case of silver as an antiseptic, the antibacterinl action and effects on indolent wounds and burns (Wright et al, 1999) have been established (Demling and DeSanti, 2001) . It has been stated that silver can 'provide a disinfected surface in the immediate environment of the wound, thus preventing bacterial infection ' (Williams, 1997) .
For iodine as iodophor or cadexomer preparations, the consensus is in favour of its use in non-healing and infected chronic wounds (Gilchrist, 1997a; Sundberg and Mcller, 1997) . Once the infection or critical colonization is reduced and the wound Shows signs of healing, it is advisable to chniige the dressing for one appropriate to the iieeds of thc wound.
Antiseptics nnd disinfectmts have long been die coriierstonc of effective infection control and the preveiitioti of hospitnl-nccluired infection. Wie iise of topical silver aiicl iodine containing sustained releiise forniulatioiis on infected and criticdly colnnized wo~inds can, as pair of an tiolistic approach, bc supportccl. There are several indicntioiis for use of a topical an tiseptic sustaiiied clelivery System, whether it be dressing, creatn 01' ointment:
0 If one oc moce overt sigti of infection, or any less obvious signs such as increased exudate Ievels, are preselit Increased local yain 0 Cessation of Progress in healing, tlien intervention is indicated to return the wound to health. The use of appropriate topical products .will also assist in the reduction of odour and local bioburden, thus reducing the risks of DcMariiii D , Brock KI-I, Docrr CL et nl (1988) Mutn eiiicity aod clastogcnicir of proflavin in 
